Evidence map›Paper›PMID 41362103›Full record

ArticleSubstance use & misuse2026

Patterns of Felt Stigma Among Rural-Dwelling People Who Use Drugs: A Latent Class Analysis.

Adams L Sibley, Nisha C O'Shea, Kathryn E Muessig, Seth M Noar, Caroline M Barry, Rachel E Gicquelais, Jessica J Wyse, Ryan Cook, April M Young, Judith I Tsui and 9 more

Abstract read
In one paragraph

Article in Substance use & misuse, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors.

Adams L SibleyInjury Prevention Research Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.ORCID 0000-0001-5073-8677
Nisha C O'SheaRTI International, Research Triangle Park, North Carolina, USA.
Kathryn E MuessigCollege of Nursing, Institute on Digital Health and Innovation, Florida State University, Tallahassee, Florida, USA.
Seth M NoarHussman School of Journalism and Media, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
Caroline M BarryRollins School of Public Health, Emory University, Atlanta, Georgia, USA.
Rachel E GicquelaisSchool of Medicine and Public Health, University of Wisconsin-Madison, Madison, Wisconsin, USA.ORCID 0000-0002-7022-6385
Jessica J WyseSchool of Public Health, Oregon Health & Science University-Portland State University, Portland, Oregon, USA.
Ryan CookDivision of General Internal Medicine and Geriatrics, Oregon Health & Science University, Portland, Oregon, USA.
April M YoungCollege of Public Health, University of Kentucky, Lexington, Kentucky, USA.
Judith I TsuiSchool of Medicine, University of Washington, Seattle, Washington, USA.
L Sarah MixsonSchool of Medicine, University of Washington, Seattle, Washington, USA.
Gordon S SmithSchool of Public Health, West Virginia University, Morgantown, West Virginia, USA.
Judith FeinbergSchool of Medicine, West Virginia University, Morgantown, West Virginia, USA.
David W SealSchool of Public Health and Tropical Medicine, Tulane University, New Orleans, Louisiana, USA.
Wiley D JenkinsCollege of Behavioral, Social, and Health Sciences, Clemson University, Clemson, South Carolina, USA.
Peter D FriedmannUniversity of Massachusetts Chan Medical School-Baystate, Springfield, Massachusetts, USA.
Dalia KhouryRTI International, Research Triangle Park, North Carolina, USA.
William C MillerGillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
Vivian F GoGillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.

Funding

Rural Comorbidity and HIV consequences of Opioid use Research and Treatment Initiative (Rural cohort)U24DA048538 · NIDA · UNIVERSITY OF WASHINGTON · PI CRANE, HEIDI M., TSUI, JUDITH · 2019 to 2023
$3.7M
Training in Advanced Data Analytics to End Drug-Related Harms (TADA)T32DA050552 · NIDA · EMORY UNIVERSITY · PI Howard H Chang, Hannah LF Cooper · 2020 to 2026
$1.6M
Drug Injection Surveillance and Care Enhancement for Rural Northern New England (DISCERNNE)UG3DA044830 · NIDA · BAYSTATE MEDICAL CENTER, INC. · PI FRIEDMANN, PETER D · 2017 to 2018
$1.6M
Community-based, client-centered prevention homes to address the rural opioid epidemicUG3DA044826 · NIDA · UNIVERSITY OF WISCONSIN-MADISON · PI SEAL, DAVID W, WESTERGAARD, RYAN PATRICK · 2017 to 2018
$1.4M
Kentucky Communities & Researchers Engaging to Halt the Opioid Epidemic-CARE2HOPEUG3DA044798 · NIDA · UNIVERSITY OF KENTUCKY · PI COOPER, HANNAH LF, YOUNG, APRIL MARIE · 2017 to 2018
$1.3M
Mitigating the Outcomes Associated with the Injection Drug Use Epidemic in Southern AppalachiaUG3DA044823 · NIDA · RESEARCH TRIANGLE INSTITUTE · PI ZULE, WILLIAM A · 2017 to 2018
$1.2M
Implementing a Community-Based Response to the Opioid Epidemic in Rural OhioUG3DA044822 · NIDA · OHIO STATE UNIVERSITY · PI GO, VIVIAN F., MILLER, WILLIAM C · 2017 to 2018
$1.1M
Ending transmission of HIV, HCV, and STDs and overdose in rural communities of people who inject drugs (ETHIC)UG3DA044829 · NIDA · UNIVERSITY OF CHICAGO · PI JENKINS, WILEY, PHO, MAI TUYET · 2017 to 2018
$1.1M
Rural West Virginia Responds to Opioid Injection Epidemics: From Data to ActionUG3DA044825 · NIDA · WEST VIRGINIA UNIVERSITY · PI FEINBERG, JUDITH, SMITH, GORDON STEPHEN · 2017 to 2018
$1.0M
Oregon HIV/Hepatitis and Opioid Prevention and Engagement (OR-HOPE) StudyUG3DA044831 · NIDA · OREGON HEALTH & SCIENCE UNIVERSITY · PI KORTHUIS, PHILIP TODD · 2017 to 2018
$895k
Determining the Feasibility and Acceptability of a Novel Stigma Resistance Text Message Intervention for People who Use DrugsF31DA058452 · NIDA · UNIV OF NORTH CAROLINA CHAPEL HILL · PI SIBLEY, ADAMS LONGSTREET · 2023 to 2024
$58k
NIDA NIH HHS F31 DA058452NIDA NIH HHS T32 DA050552NIDA NIH HHS U24 DA048538NIDA NIH HHS UG3 DA044798NIDA NIH HHS UG3 DA044822NIDA NIH HHS UG3 DA044823NIDA NIH HHS UG3 DA044825NIDA NIH HHS UG3 DA044826NIDA NIH HHS UG3 DA044829NIDA NIH HHS UG3 DA044830NIDA NIH HHS UG3 DA044831
6 · The paper itself

Abstract

backgroundStigma is a barrier to help-seeking in rural-dwelling people who use drugs. However, little is known about whether stigma is experienced in patterned ways, and what characteristics are associated with these patterns.

methodsData came from a cohort of people who use drugs at eight geographically diverse Rural Opioid Initiative sites (

resultsBased on fit statistics and interpretability, we selected a five-class solution. Four classes were patterned by severity: Low Stigma (23.7%), Medium-Low Stigma (12.5%), Medium-High Stigma (34.9%), and High Stigma (24.7%). The fifth class ("High Fearers/Low Perceivers," 4.3%) reported high shame and fear of rejection but low perceived stigma from others. Members of higher stigma classes were more likely to have criminal-legal system involvement, inject drugs, and avoid healthcare and drug treatment. In contrast analyses, "High Fearers/Low Perceivers" were more likely to be younger and women, and less likely to have criminal-legal system involvement, experience homelessness, or inject drugs compared with other classes.

conclusionRural people who use drugs experience substance use stigma in distinct severity-based patterns, with four classes ranging from low to high stigma across all dimensions. A fifth, smaller class reports high internalized stigma despite low perceived stigma from others, potentially suggesting non-disclosure of substance use. These distinct profiles and their correlates offer targets for tailored stigma interventions.

Indexed as

Drug UsersRural PopulationSocial StigmaSubstance-Related DisordersAdultFemaleHumansLatent Class AnalysisMaleMiddle Agedlatent class analysisopioidsrural healthStigmasubstance use

Identifiers

PMID41362103
PMCPMC13264826

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.